pharmaceutical companies

Local production of pharma raw materials gaining traction

Pharmaceutical companies are gradually enhancing their capacity to produce the raw materials needed to make medicines, which will go on to reduce Bangladesh’s over-reliance on imports and augment the country’s competitive edge in the global market. 

Rising dollar price hurts Renata’s profit

Pharmaceutical company Renata Ltd witnessed a 35 per cent year-on-year drop in net profit in the October-December period due to increased price of raw material generated by the dollar crisis. 

Gas, power price hike: Pharma sector fears 25% rise in production cost

Medical treatments are about to get costlier as production cost for manufacturing  drugs will go up by at least 25 per cent following a recent hike in gas and power charges, according to manufacturers.

Renata’s Rajendrapur facility wins US FDA approval

Drug maker Renata Ltd has secured approval from the US Food and Drug Administration (USFDA) for its general facility in Rajendrapur.

Profit growth of listed pharmaceutical companies slows

The pace of profit growth of pharmaceutical companies in Bangladesh slowed in the January-March period of the current financial year compared to a year ago because of higher operating costs despite bigger sales.

March 20, 2023
March 20, 2023

Local production of pharma raw materials gaining traction

Pharmaceutical companies are gradually enhancing their capacity to produce the raw materials needed to make medicines, which will go on to reduce Bangladesh’s over-reliance on imports and augment the country’s competitive edge in the global market. 

February 1, 2023
February 1, 2023

Rising dollar price hurts Renata’s profit

Pharmaceutical company Renata Ltd witnessed a 35 per cent year-on-year drop in net profit in the October-December period due to increased price of raw material generated by the dollar crisis. 

January 22, 2023
January 22, 2023

Gas, power price hike: Pharma sector fears 25% rise in production cost

Medical treatments are about to get costlier as production cost for manufacturing  drugs will go up by at least 25 per cent following a recent hike in gas and power charges, according to manufacturers.

November 3, 2022
November 3, 2022

Renata’s Rajendrapur facility wins US FDA approval

Drug maker Renata Ltd has secured approval from the US Food and Drug Administration (USFDA) for its general facility in Rajendrapur.

May 20, 2022
May 20, 2022

Profit growth of listed pharmaceutical companies slows

The pace of profit growth of pharmaceutical companies in Bangladesh slowed in the January-March period of the current financial year compared to a year ago because of higher operating costs despite bigger sales.